Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders

Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders

US Patent 12246076 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Dual mode 18F-labelled theranostic compounds and uses thereof2025
Mutant p-hydroxyphenylpyruvate dioxygenase, and coding nucleic acid and use ther2025
Reusable SERS molecule detection apparatus and use method thereof2025
Nucleic acid extraction composition, reagent and kit containing the same and use2025
Kappa opioid receptor peptide amide ligands2025
LILRB4 antibodies and uses thereof2025
Method of treating cancer using a combination of entinostat and an anti-CSF-1R a2024
Control method and system for hybrid power system2024
Selection of patients for combination therapy2024